Search

Your search keyword '"Manuel A. Patarroyo"' showing total 676 results

Search Constraints

Start Over You searched for: Author "Manuel A. Patarroyo" Remove constraint Author: "Manuel A. Patarroyo"
676 results on '"Manuel A. Patarroyo"'

Search Results

1. Immunopeptidomics of Salmonella enterica Serovar Typhimurium-Infected Pig Macrophages Genotyped for Class II Molecules

2. Plasmodium falciparum rhoptry neck protein 4 has conserved regions mediating interactions with receptors on human erythrocytes and hepatocyte membrane

3. Therapeutic Use of the Antimicrobial Peptide PNR20 to Resolve Disseminated Candidiasis in a Murine Model

4. Stereo electronic principles for selecting fully-protective, chemically-synthesised malaria vaccines

5. Identifying HLA DRB1-DQB1 alleles associated with Chlamydia trachomatis infection and in silico prediction of potentially-related peptides

6. Genetic diversity and population structure of Rhipicephalus sanguineus sensu lato across different regions of Colombia

7. SM-COLSARSPROT: Highly Immunogenic Supramutational Synthetic Peptides Covering the World’s Population

8. Establishing and characterising a new cell line from Calliphora vicina (diptera: calliphoridae) fly embryonic tissues

9. The First Chemically-Synthesised, Highly Immunogenic Anti-SARS-CoV-2 Peptides in DNA Genotyped Aotus Monkeys for Human Use

10. High frequency of toxigenic Clostridium difficile and Clostridium perfringens coinfection among diarrheic patients at health care facility-onset (HCFO) and community-onset (CO) centers in Bogotá, Colombia

11. Comparative genomics identifies potential virulence factors in Clostridium tertium and C. paraputrificum

12. How to Combat Gram-Negative Bacteria Using Antimicrobial Peptides: A Challenge or an Unattainable Goal?

13. Robust, Comprehensive Molecular, and Phenotypical Characterisation of Atypical Candida albicans Clinical Isolates From Bogotá, Colombia

14. Plasmodium vivax Cell Traversal Protein for Ookinetes and Sporozoites (CelTOS) Functionally Restricted Regions Are Involved in Specific Host-Pathogen Interactions

15. Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model

16. PvGAMA reticulocyte binding activity: predicting conserved functional regions by natural selection analysis

17. Characterising PvRBSA: an exclusive protein from Plasmodium species infecting reticulocytes

18. Parasite-Related Genetic and Epigenetic Aspects and Host Factors Influencing Plasmodium falciparum Invasion of Erythrocytes

19. The in Vitro Antigenicity of Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2) B- and T-Epitopes Selected by HLA-DRB1 Binding Profile

20. Specific β-Turns Precede PPIIL Structures Binding to Allele-Specific HLA-DRβ1* PBRs in Fully-Protective Malaria Vaccine Components

21. Size polymorphism and low sequence diversity in the locus encoding the Plasmodium vivax rhoptry neck protein 4 (PvRON4) in Colombian isolates

22. On the Evolution and Function of Plasmodium vivax Reticulocyte Binding Surface Antigen (pvrbsa)

23. Sarconesin: Sarconesiopsis magellanica Blowfly Larval Excretions and Secretions With Antibacterial Properties

24. Unveiling the Multilocus Sequence Typing (MLST) Schemes and Core Genome Phylogenies for Genotyping Chlamydia trachomatis

25. New Insights into Clostridium difficile (CD) Infection in Latin America: Novel Description of Toxigenic Profiles of Diarrhea-Associated to CD in Bogotá, Colombia

26. Identifying Potential Plasmodium vivax Sporozoite Stage Vaccine Candidates: An Analysis of Genetic Diversity and Natural Selection

27. Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions

28. Evaluating the Effect of Sarconesiopsis magellanica (Diptera: Calliphoridae) Larvae-Derived Haemolymph and Fat Body Extracts on Chronic Wounds in Diabetic Rabbits

31. Mycobacterium tuberculosis Rv0292 Protein Peptides Could be Included in a Synthetic Anti-tuberculosis Vaccine

33. Clinical manifestations and immune response to tuberculosis

35. The molecular basis for peptide-based antimalarial vaccine development targeting erythrocyte invasion by P. falciparum

36. The Black Box of Cellular and Molecular Events of

37. Microbial Interdomain Interactions Delineate the Disruptive Intestinal Homeostasis in Clostridioides difficile Infection

38. Malaria: Paving the way to developing peptide-based vaccines against invasion in infectious diseases

42. P002 Antifungal activity of antimicrobial synthetic peptides against Candida species of public health importance

43. Gut microbiota composition in health-care facility-and community-onset diarrheic patients with Clostridioides difficile infection

44. Trichomonas vaginalis follow-up and persistence in Colombian women

46. Adjuvants approved for human use: What do we know and what do we need to know for designing good adjuvants?

47. Changes in the Cervical Microbiota of Women with Different High-Risk Human Papillomavirus Loads

48. Identification of Babesia bovis MSA-1 functionally constraint regions capable of binding to bovine erythrocytes

49. Diagnostic Potential of the Serological Response to Synthetic Peptides from Mycobacterium tuberculosis Antigens for Discrimination Between Active and Latent Tuberculosis Infections

50. Strong-LAMP Assay Based on a Strongyloides spp.-Derived Partial Sequence in the 18S rRNA as Potential Biomarker for Strongyloidiasis Diagnosis in Human Urine Samples

Catalog

Books, media, physical & digital resources